Fact CheckerSign in

NCT02701153Recruiting

Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

Source: ClinicalTrials.gov · Last updated 10 Mar 2026

Brief summary (registry, in English)

This phase II trial studies the side effects of hypofractionated radiation therapy in treating patients with soft tissue sarcomas prior to surgery. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
51 (estimated)
First submitted
2 Mar 2016
Start date
3 Feb 2016
Primary completion date
3 Feb 2027
Lead sponsor
Jonsson Comprehensive Cancer Center
Diseases
Sarcoma
NCT number
NCT02701153

What you commit to

  • Study type: Interventional
  • Planned participants: 51
  • From 3 Feb 2016 to the primary completion date, 3 Feb 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • History of prior irradiation to the area to be treated
  • Pre-operative chemotherapy (post-op acceptable)

Other illness

  • Active treatment of a separate malignancy

Who the study is looking for

  • Histologically confirmed soft tissue sarcoma of the extremity/trunk
  • Intermediate or high grade sarcoma
  • Resectable primary lesion (patients with pre-existing metastasis will be included if their primary is still going to be resected)
  • Recurrent, any grade, no previous radiation therapy
  • Karnofsky performance status (KPS) \>= 70 or Eastern Cooperative Oncology Group (ECOG) 0 - 2
  • If a woman is of childbearing potential, a negative serum pregnancy test must be documented

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UCLA / Jonsson Comprehensive Cancer Center
Coordinator of this site? Confirm its status
Los AngelesUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.